The following parameters showed significant differences between the control and methylprednisolone-treated groups, as demonstrated in the following figures: IL-6 following surgery (Fig. 1); IL-6 on postoperative day (POD) 1 (Fig. 2); IL-6 on POD 3 (Fig. 3); IL-8 following surgery (Fig. 4); PaO2/FiO2 on POD 3 (Fig. 5); failure of any organ (Fig. 6); cardiovascular disorders (Fig. 7); and pulmonary disorders (Fig. 8). The gene discussed is CXCL8; the disease is cardiovascular disorder.